Currently holds positions in Theravance Biopharma Inc, OncoMed Pharmaceuticals Inc and Jazz Pharmaceuticals PLC
Position | Company | Period |
---|---|---|
Chairman of the Board, Chief Executive Officer | Theravance Biopharma Inc | None - |
Director | OncoMed Pharmaceuticals Inc | June 24, 2015 - |
Independent Director | Jazz Pharmaceuticals PLC | May 1, 2010 - |
Chairman of the Board | Innoviva Inc | Aug. 15, 2014 - Oct. 30, 2014 |
Chairman of the Board, Chief Executive Officer | Innoviva Inc | April 1, 2010 - Aug. 15, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-15 | 2023-08-14 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
1,241
-10.6%
138.16171,455 USD |
1,241 -10.6% | 138.16 | 171,455 USD | |
2022-12-16 | 2022-12-14 |
Theravance Biopharma Inc
(TBPH)
|
S Sale |
50,000
-3.6%
11.19559,500 USD |
50,000 -3.6% | 11.19 | 559,500 USD | |
2022-08-09 | 2022-08-08 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
1,089
-11.2%
152.32165,879 USD |
1,089 -11.2% | 152.32 | 165,879 USD | |
2020-08-10 | 2020-08-07 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
931
-13.1%
125.87117,185 USD |
931 -13.1% | 125.87 | 117,185 USD | |
2018-08-13 | 2018-08-10 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
660
-11.8%
176.61116,563 USD |
660 -11.8% | 176.61 | 116,563 USD | |
2016-08-17 | 2016-08-15 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
633
-4.0%
136.4586,373 USD |
633 -4.0% | 136.45 | 86,373 USD |